A detailed history of Tower Research Capital LLC (Trc) transactions in Care Dx, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 600 shares of CDNA stock, worth $12,912. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 7,451 91.95%
Holding current value
$12,912
Previous $115,000 84.35%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$14.41 - $33.99 $98,722 - $232,865
-6,851 Reduced 91.95%
600 $18,000
Q2 2024

Aug 13, 2024

BUY
$7.56 - $16.15 $15,928 - $34,028
2,107 Added 39.43%
7,451 $115,000
Q1 2024

May 15, 2024

SELL
$7.96 - $12.37 $323,979 - $503,471
-40,701 Reduced 88.39%
5,344 $56,000
Q4 2023

Feb 13, 2024

BUY
$4.9 - $12.86 $219,441 - $575,922
44,784 Added 3551.47%
46,045 $552,000
Q3 2023

Nov 14, 2023

SELL
$7.0 - $11.26 $65,884 - $105,979
-9,412 Reduced 88.19%
1,261 $8,000
Q2 2023

Aug 14, 2023

SELL
$7.61 - $9.46 $197,121 - $245,042
-25,903 Reduced 70.82%
10,673 $90,000
Q1 2023

May 09, 2023

BUY
$8.83 - $17.61 $311,019 - $620,277
35,223 Added 2603.33%
36,576 $334,000
Q4 2022

Feb 10, 2023

SELL
$10.88 - $20.05 $276,362 - $509,290
-25,401 Reduced 94.94%
1,353 $16,000
Q3 2022

Nov 10, 2022

BUY
$16.06 - $26.39 $213,726 - $351,198
13,308 Added 98.97%
26,754 $456,000
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $258,973 - $502,021
12,639 Added 1566.17%
13,446 $289,000
Q1 2022

May 12, 2022

BUY
$28.19 - $46.6 $4,031 - $6,663
143 Added 21.54%
807 $30,000
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $41,612 - $74,336
-1,010 Reduced 60.33%
664 $30,000
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $367,617 - $571,717
-6,215 Reduced 78.78%
1,674 $106,000
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $10,083 - $15,217
-160 Reduced 1.99%
7,889 $722,000
Q1 2021

May 17, 2021

BUY
$57.62 - $95.6 $33,650 - $55,830
584 Added 7.82%
8,049 $548,000
Q4 2020

Feb 16, 2021

BUY
$41.43 - $77.09 $223,431 - $415,746
5,393 Added 260.28%
7,465 $541,000
Q3 2020

Nov 16, 2020

SELL
$30.88 - $37.94 $15,841 - $19,463
-513 Reduced 19.85%
2,072 $79,000
Q2 2020

Aug 13, 2020

BUY
$18.95 - $35.43 $48,985 - $91,586
2,585 New
2,585 $92,000
Q4 2019

Feb 07, 2020

SELL
$19.24 - $28.41 $2,251 - $3,323
-117 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$20.03 - $40.08 $2,343 - $4,689
117 New
117 $3,000
Q2 2019

Aug 13, 2019

SELL
$25.78 - $39.77 $1,546 - $2,386
-60 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$22.09 - $39.21 $1,325 - $2,352
60 New
60 $2,000
Q4 2018

Feb 14, 2019

SELL
$19.89 - $30.02 $2,903 - $4,382
-146 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$12.1 - $28.85 $556 - $1,327
46 Added 46.0%
146 $4,000
Q2 2018

Aug 15, 2018

SELL
$7.93 - $15.79 $4,163 - $8,289
-525 Reduced 84.0%
100 $1,000
Q1 2018

May 15, 2018

BUY
$5.18 - $7.97 $3,237 - $4,981
625 New
625 $5,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.